WCG

WCG Expands New Statistical Consulting Solutions to Address Industry Resource Challenges

Retrieved on: 
Monday, March 4, 2024

PRINCETON, N.J., March 4, 2024 /PRNewswire/ -- WCG, the global leader in providing solutions that measurably improve and accelerate clinical research, announces the expansion of its capabilities with the introduction of Statistical Consulting Solutions.

Key Points: 
  • PRINCETON, N.J., March 4, 2024 /PRNewswire/ -- WCG, the global leader in providing solutions that measurably improve and accelerate clinical research, announces the expansion of its capabilities with the introduction of Statistical Consulting Solutions.
  • Developed to combat some of the pervasive challenges involving resource constraints throughout the clinical research industry, this innovative offering aims to revolutionize how organizations approach statistical analysis and decision-making.
  • WCG's Statistical Consulting Solutions empower biotechnology firms, CROs, pharmaceutical companies, medical device manufacturers, government agencies, and non-profit organizations with comprehensive statistical support across all stages of trial design and regulatory strategy.
  • Whether assisting with early phase studies or providing support for regulatory submissions, WCG's Statistical Consulting Solutions are tailored to meet the diverse needs of the industry.

Optoma UHZ55 Smart UHD Laser Projector Brings Home Entertainment to New Levels

Retrieved on: 
Wednesday, February 21, 2024

FREMONT, Calif., Feb. 21, 2024 /PRNewswire/ -- Today, Optoma, the No. 1 4K UHD and DLP® brand worldwide and in the Americas in projection technology,¹ introduced the Optoma UHZ55, a lightning-fast, long-lasting smart UHD laser projector. The UHZ55 laser projector joins the company's line of award-winning true 4K resolution projectors, including its predecessor, the popular UHZ50, and is designed for all home entertainment and home office needs. With 3,000 lumens, a 2,500,000:1 contrast ratio, easy installation features, and Optoma's DuraCore laser light source, the new UHZ55 delivers razor-sharp images and lights-on viewing for all of your home entertainment, gaming, and work-from-home needs.

Key Points: 
  • New Optoma UHZ55 delivers razor sharp, vibrant images for long-lasting home entertainment experience
    FREMONT, Calif., Feb. 21, 2024 /PRNewswire/ -- Today, Optoma , the No.
  • 1 4K UHD and DLP® brand worldwide and in the Americas in projection technology,¹ introduced the Optoma UHZ55, a lightning-fast, long-lasting smart UHD laser projector.
  • The UHZ55 laser projector joins the company's line of award-winning true 4K resolution projectors, including its predecessor, the popular UHZ50, and is designed for all home entertainment and home office needs.
  • Designed with Texas Instruments' DLP® technology and Optoma's DuraCore laser technology, the UHZ55 projector's laser light source allows for up to 30,000 hours of maintenance-free use.

WCG ClinSphere™: Revolutionizing Clinical Research Technology

Retrieved on: 
Monday, February 12, 2024

PRINCETON, N.J., Feb. 12, 2024 /PRNewswire/ -- WCG, the global leader in providing solutions that measurably improve and accelerate clinical research, announces the upcoming launch of WCG ClinSphere™ , a revolutionary technology platform designed to enable an efficient and optimized clinical research process by leveraging data, insights, and artificial intelligence to connect sites, sponsors, CROs, and participants on a unified, cloud-based system.

Key Points: 
  • PRINCETON, N.J., Feb. 12, 2024 /PRNewswire/ -- WCG, the global leader in providing solutions that measurably improve and accelerate clinical research, announces the upcoming launch of WCG ClinSphere™ , a revolutionary technology platform designed to enable an efficient and optimized clinical research process by leveraging data, insights, and artificial intelligence to connect sites, sponsors, CROs, and participants on a unified, cloud-based system.
  • WCG ClinSphere is poised to reimagine traditional clinical research processes with its advanced capabilities, accelerating research timelines, streamlining workflows, and strengthening collaboration throughout the clinical research ecosystem.
  • WCG's Chief Technology Officer, Paul Mancinelli, PhD, added, "WCG ClinSphere is the culmination of cutting-edge technology and years of expertise in the clinical research domain.
  • Embodying WCG's commitment to efficiency and optimization in clinical trials, the name "Clin" aptly reflects its core purpose in clinical research.

Fortrea Previews J.P. Morgan Healthcare Conference Updates

Retrieved on: 
Monday, January 8, 2024

DURHAM, N.C., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (“CRO”), today previewed key updates that Tom Pike, chairman and chief executive officer, and Jill McConnell, chief financial officer, plan to present at the 42nd Annual J.P. Morgan Healthcare Conference.

Key Points: 
  • DURHAM, N.C., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (“CRO”), today previewed key updates that Tom Pike, chairman and chief executive officer, and Jill McConnell, chief financial officer, plan to present at the 42nd Annual J.P. Morgan Healthcare Conference.
  • Fortrea recently hired a recognized industry expert and leader in artificial intelligence (AI) to lead Fortrea’s efforts in AI and machine learning.
  • Fortrea hired Dr. Lindsay McNair MD, MPH, MS Bioethics, to review Fortrea’s conduct of the two clinical trials.
  • Dr. McNair was given full access to information and personnel available to Fortrea and performed her own independent assessment.

WCG Announces Release of Clinical Research Trends & Insights 2024 Report

Retrieved on: 
Thursday, January 4, 2024

"There is continued focus on protecting the rights and safety of participants and prioritizing diversity in the clinical trials space.

Key Points: 
  • "There is continued focus on protecting the rights and safety of participants and prioritizing diversity in the clinical trials space.
  • It will be through novel uses of data, technology, and integrated workflows that will allow us to reimagine how we accelerate clinical research.
  • These influential changes demand a deeper understanding and examination of the impact they will undoubtedly have on the clinical research industry."
  • The report delves into the increasing role of AI and machine learning in clinical research, patient recruitment barriers in oncology trials, clinical trial site trends for 2024, diversity, equity and inclusion considerations in rare disease trials, and the promise of psychedelic treatments.

WCG Expands Board of Directors with Three Distinguished Appointments

Retrieved on: 
Monday, December 18, 2023

PRINCETON, N.J., Dec. 18, 2023 /PRNewswire/ -- WCG, the global leader in providing solutions that improve and accelerate clinical research, is pleased to announce the appointment of three industry leaders to its board of directors.

Key Points: 
  • PRINCETON, N.J., Dec. 18, 2023 /PRNewswire/ -- WCG, the global leader in providing solutions that improve and accelerate clinical research, is pleased to announce the appointment of three industry leaders to its board of directors.
  • Ken Getz is the executive director of the Tufts Center for the Study of Drug Development and a renowned industry thought leader.
  • WCG's Chief Executive Officer, Sam Srivastava, expressed enthusiasm about the new appointments, stating, "We are thrilled to welcome Ken, Bob, and Amrit to our already talented board of directors.
  • These additions to the board of directors will further strengthen WCG's position as a thought leader and trusted partner in clinical research.

Parexel Named “Best Contract Research Organization” at 19th Annual Scrip Awards

Retrieved on: 
Friday, November 17, 2023

DURHAM, N.C., Nov. 17, 2023 (GLOBE NEWSWIRE) -- Parexel , one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services, today announced today announced it has been named “Best Contract Research Organization” in the Full-Service Provider category at the 19th Annual Scrip Awards.

Key Points: 
  • DURHAM, N.C., Nov. 17, 2023 (GLOBE NEWSWIRE) -- Parexel , one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services, today announced today announced it has been named “Best Contract Research Organization” in the Full-Service Provider category at the 19th Annual Scrip Awards.
  • “Parexel colleagues are passionate about developing life-changing new therapies to advance world health,” said Chief Executive Officer Jamie Macdonald.
  • Winners were named across 14 categories, including Best Contract Research Organization, which recognizes the critical role CROs play in the drug development process.
  • Parexel was recognized at the Scrip Awards ceremony Nov. 16 in London.

WCG Revolutionizes Ethical Review Process with IRB+ Service, Achieving Unprecedented Efficiency Gains

Retrieved on: 
Thursday, November 30, 2023

Mark McDonald, president, WCG Review Solutions, expressed his enthusiasm for the launch, "IRB+ represents a significant leap forward in our commitment to advancing the efficiency and quality of clinical trial processes.

Key Points: 
  • Mark McDonald, president, WCG Review Solutions, expressed his enthusiasm for the launch, "IRB+ represents a significant leap forward in our commitment to advancing the efficiency and quality of clinical trial processes.
  • We've taken a bold step in addressing the critical need for accelerated review processing without compromising the high standards of ethical oversight.
  • "IRB+ provides a tailored solution for those looking to optimize their study timelines without compromising the quality or integrity of the ethical review.
  • WCG's IRB+ marks a new era in clinical trial efficiency, combining cutting-edge technology, dedicated expertise, and a commitment to ethical oversight and participant safety.

Global Investigative Sites Recognize Parexel with the 2023 Society for Clinical Research Sites Eagle Award

Retrieved on: 
Thursday, October 12, 2023

DURHAM, N.C., Oct. 12, 2023 (GLOBE NEWSWIRE) -- Parexel , one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services, today announced it has been awarded the 2023 Society for Clinical Research Sites (SCRS) Eagle Award (CRO category).

Key Points: 
  • DURHAM, N.C., Oct. 12, 2023 (GLOBE NEWSWIRE) -- Parexel , one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services, today announced it has been awarded the 2023 Society for Clinical Research Sites (SCRS) Eagle Award (CRO category).
  • Parexel received the award at the annual Global Site Solutions Summit held Oct. 6-8 in Hollywood, Fla.
  • The SCRS Eagle Award recognizes the sponsor and CRO committed to outstanding leadership, professionalism, integrity, passion and dedication to advancing the clinical research profession through strong site partnerships.
  • SCRS is the leading advocacy organization with a mission to unify the voice of the global clinical research site community.

Town of Westport CT School Building Committee Recommends Destruction of Nationally Awarded Community Garden and Preserve

Retrieved on: 
Friday, October 6, 2023

The Westport CT Long Lots School Building Committee (the “Committee”), appointed by First Selectwoman Jen Tooker, voted yesterday (October 5th) to submit a recommendation which includes the removal of the current Westport Community Gardens and Preserve as well as a portion of the adjacent Long Lots Preserve, a newly established model of suburban environmental rehabilitation.

Key Points: 
  • The Westport CT Long Lots School Building Committee (the “Committee”), appointed by First Selectwoman Jen Tooker, voted yesterday (October 5th) to submit a recommendation which includes the removal of the current Westport Community Gardens and Preserve as well as a portion of the adjacent Long Lots Preserve, a newly established model of suburban environmental rehabilitation.
  • It is not part of the school rebuilding specifications, but rather falls under the town’s Parks and Recreation activities.
  • “This is a pork barrel appropriation for ball fields, under the cover of a much-needed new elementary school.
  • “How do you recover from that?”
    The Committee chose to make its recommendation despite widespread opposition from members of the community.